Skip to content

Xengenic Cortical Membranes Versus Connective Tissue Graft With Coronally Advanced Flap for the Treatment of Peri-implant Soft Tissue Dehiscences: A Randomized, Controlled Clinical Trial

Xengenic Cortical Membranes Versus Connective Tissue Graft With Coronally Advanced Flap for the Treatment of Peri-implant Soft Tissue Dehiscences: A Randomized, Controlled Clinical Trial

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06588998
Enrollment
20
Registered
2024-09-19
Start date
2024-06-01
Completion date
2024-12-30
Last updated
2024-09-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Connective Tissue Graft, Immediate Implant

Brief summary

Peri-implant soft tissue dehiscences represent a common complication in implant dentistry, often leading to esthetic and functional challenges. Current treatment options, including Xengenic cortical membranes and connective tissue graft with coronally advanced flap, aim to promote soft tissue regeneration and improve clinical outcomes. However, there is a need for comparative studies to determine the optimal treatment modality for peri-implant soft tissue dehiscences.

Detailed description

Aim: Comparing the effectiveness and patient outcomes of Xengenic cortical membranes versus connective tissue graft with coronally advanced flap for the treatment of peri-implant soft tissue dehiscences.

Interventions

DEVICEXengenic Cortical membranes

soft tissue surgery around dental implant dehiscence

PROCEDUREconnective tissue graft

soft tissue surgery around dental implant dehiscence

Sponsors

Amr Anwar Mohamed Ellithy Yousef
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
20 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* Adults (20-50) years old. •peri-implant soft tissue dehiscence . •Thin gingival phenotype. •Optimal compliance as evidenced by no missing treatment appointments and positive attitude towards oral hygiene.

Exclusion criteria

* •Medically compromised patients and systemic conditions precluding implant and periodontal surgery. •Smokers, diabetics, pregnant or lactating women. •History of chemotherapy, radiotherapy in head and/or neck region. •Bisphosphonate therapy.

Design outcomes

Primary

MeasureTime frame
peri implant soft tissue thicknesssix months

Secondary

MeasureTime frame
pink esthetic scoresix months

Countries

Egypt

Contacts

Primary Contactamr anwar ellithy, MSC
amr.yousef@dent.tanta.edu.eg00201066767062
Backup Contactbassem nabil elfahl, PHD
+20 114 009 0390

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026